Stock PMDS PMD DEVICE SOLUTIONS AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials PMD Device Solutions AB

Equities

PMDS

SE0021513645

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:48 2024-04-26 am EDT 		5-day change 1st Jan Change
7.55 SEK -5.03% Intraday chart for PMD Device Solutions AB -12.72% -33.12%
Apr. 11 PMD Device Solutions AB (OM:PMDS) acquired Coala Life Inc from Coala-Life Group AB for SEK 3.6 million. CI
Apr. 09 PMD Device Solutions to Purchase Coala-Life Group's US Unit MT

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 157.4 - -
Enterprise Value (EV) 1 154.4 38.41 157.4
P/E ratio - - -
Yield - - -
Capitalization / Revenue 3.21 x 2.04 x 1.17 x
EV / Revenue 3.15 x 0.5 x 1.17 x
EV / EBITDA 154 x 12.8 x 15.7 x
EV / FCF 77.2 x -1.83 x -
FCF Yield 1.3% -54.7% -
Price to Book - - -
Nbr of stocks (in thousands) 20,849 - -
Reference price 2 7.550 7.550 7.550
Announcement Date - - -
1SEK in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2024 2025 2026
Net sales 1 49 77 134
EBITDA 1 1 3 10
EBIT 1 -4 -2 5
Operating Margin -8.16% -2.6% 3.73%
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Free Cash Flow 1 2 -21 -
FCF margin 4.08% -27.27% -
FCF Conversion (EBITDA) 200% - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2024 2025 2026
Net Debt 1 - - -
Net Cash position 1 3 119 -
Leverage (Debt/EBITDA) - - -
Free Cash Flow 1 2 -21 -
ROE (net income / shareholders' equity) - - -
ROA (Net income/ Total Assets) - - -
Assets - - -
Book Value Per Share - - -
Cash Flow per Share - - -
Capex 1 4 6 -
Capex / Sales 8.16% 7.79% -
Announcement Date - - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
PMD DEVICE SOLUTIONS AB Stock PMD Device Solutions AB
-33.12% 14.36M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. PMDS Stock
  4. Financials PMD Device Solutions AB